$KITE Kite Pharma, Inc. Insider Trading Week 25/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 25/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 27 2014 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Option Exercise | C | 0.00 | 1,885,551 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Buy | C | 0.00 | 1,892,840 | 0 | 1,892,840 | 0 to 1.9 M |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Buy | J | 15.30 | 66,014 | 1,010,014 | 66,014 | 0 to 66 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 313,531 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 807,681 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | C | 0.00 | 1,072,245 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 314,743 | 0 | 314,743 | 0 to 314.7 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 810,803 | 0 | 810,803 | 0 to 810.8 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Buy | C | 0.00 | 1,076,390 | 0 | 1,076,390 | 0 to 1.1 M |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | C | 2.04 | 40,000 | 81,536 | 40,000 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | C | 1.73 | 40,000 | 69,200 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | C | 0.00 | 31,743 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | C | 0.00 | 138,532 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Buy | C | 0.00 | 31,865 | 0 | 31,865 | 0 to 31.9 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Buy | C | 0.00 | 139,067 | 0 | 139,067 | 0 to 139.1 K |
Jun 27 2014 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | C | 0.00 | 2,158,545 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Buy | J | 15.30 | 759,170 | 11,615,301 | 2,926,059 | 2.2 M to 2.9 M (+35.04 %) |
Jun 27 2014 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Buy | C | 0.00 | 2,166,889 | 0 | 2,166,889 | 0 to 2.2 M |
Jun 27 2014 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Option Exercise | C | 0.00 | 2,349,004 | 0 | 0 | |
Jun 27 2014 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Buy | C | 0.00 | 2,358,084 | 0 | 2,358,084 | 0 to 2.4 M |
Jun 23 2014 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | A | 17.00 | 50,000 | 850,000 | 50,000 | |
Jun 23 2014 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | A | 17.00 | 50,000 | 850,000 | 50,000 | |
Jun 23 2014 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | A | 17.00 | 149,511 | 2,541,687 | 149,511 |